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One-hundred-eighty kilodalton bullous pemphigoid anti-
gen (BPAG2) is recognized by autoantibodies in the sera of 
patients with blistering skin diseases, bullous pemphigoid 
(BP), and herpes gestationis (HG). In this study, we have 
screened a mouse epidermal keratinocyte cDNA library with 
a 1.0-kb human BPAG2 cDNA, which h as been shown to 
correspond to two collagenous domains (Giudice et al: J Clin 
Invest 87:734-738, 1991). Screening of the mouse library 
identified two cDNA clones, the larger one being 1.8 kb in 
size. Comparison of the mouse amino acid sequences, as de-
duced from cDNA, with the corresponding human se-
quences revealed 86% homology. Furthermore, Northern 
hybridizations of mouse epidermal RNA with these cDNA 
revealed the' presence of an mRNA transcript of -6 kb, the 
size of the human BPAG2 mRNA. Elucidation of the de-
T he cutaneous basement membrane zone (BMZ) en-compasses a basement membrane network that sepa-rates the epidermal basal cells and the adjacent papil-lary dermis [1 - 3]. The epidermal basal cells adhere to the basement membrane via hemidesmosomes, mem-
brane-associated organelles that, until recently, have eluded detailed 
biochemical analysis due to the lack of specific markers . Immuno-
electron microscopic studies, performed by our laboratory [4] and 
others [5,6], have demonstrated that autoantibodies from bullous 
pemphigoid (BP) patients specifically recognize hemidesmosomal 
antigens. Immunoblotting and immunoprecipitation techniques 
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duced amino-acid sequences revealed the presence of defi-
nitely one and possibly two putative m embrane-associated 
segments, suggesting that the 180-kDa BP antigen is a trans-
m embrane protein. The sequence an alysis also identified a 
7 - amino-acid segment that was predicted by computer anal-
ysis to be antigenic. Elucidation of the divergence between 
the mouse and previously published human and chicken 
BPAG2 sequences indicated that this protein segment was 
relatively well conserved. These data suggest, therefore, that 
the 180-kDa bullous pemphigoid antigen associated With 
hemidesmosomes is a well-conserved transmembrane pro-
tein that may playa critical role in the attichment of epider-
mis to the underlying basem ent membrane.] Invest Dermato! 
99:258-263, 1992 
have identified two BP autoantibody-reactive antigens with appar-
ent molecular weights of 230 and 180 kDa (referred to here as BP 
antigen-l and -2 [BPAG l and BPAG2]. respectively) [7,8]. In addi-
tion, the sera of patients with herpes gestationis (HG), a pregnan~Y­
associated subepidermal disease, were also shown to recogniZe 
BPAG2 [9]. 
Further characterization of the BPAG has recently been advanced 
by cloning of the corresponding cD NA [10,11]. Specifically, clon-
ing of a full- length cD NA corresponding to human BPAG 1 se-
quences has revealed biologically important peptide segments and 
protein domains [12] . Furthermore, a 1.0-kb cDNA (BP180 
cDNA) corresponding to human BPAG2 sequences has been pub-
lished [13]. The deduced amino-acid sequences identified twO col-
lagenous domains characterized by the repeating Gly-X-y .se-
quence. These collagenous domains consisted of 242 and 30 ammo 
acids, respectively, separated by a 12-amino-acid non_collagenoUS 
segment. The large collagenous domain contained a single imper-
fection, Gly-Ser-Gly, interrupting the Gly-X-Y repeat sequence 
[13] . Elucidation of the exon-intron arrangement of the corr~­
sponding segment in the human BPAG2 gene revealed that thIS 
coding segment consisted of 19 separate exons varying from 27 to 
222 bp in size [14] . The organization of these exons and the sphce 
sites at the intron-exon junctions were clearly different fr0111 othr 
fibrill ar and non-fibrillar collagen genes described to date. ~ 1e 
b 'd za-BPAG2 gene was also mapped by chromosomal in situ hy rt I 3 
tion to the long arm of human chromoso me 10, at locus 10q24. 
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[14] . This location is distinct from any previously mapped collagen 
genes or from the map position of BPAG 1 at locus 6pll-12 [15]. 
These observations suggested that human BPAG2 is a novel collage-
nous protein containing non-collagenous interruptions and imper-
fections. 
During elucidation of the 180-kDa BPAG2 sequences, it became 
clear that the human cDNA had striking similarities with a recently 
Isolated chicken cDNA that predicted a collagenous protein sug-
gested to be a "cornea-specific co llagen" [16]. Strikingly, the largest 
collagenous segment in the chicken protein consisted of242 amino 
aCids in the G ly-X-Y repeat, with one Gly-Phe-Gly imperfection. 
Downstream from this collagenous domain, there was a putative 
non-collagenous domain of 12 amino acids, followed by another 
collagenous domain of 39 amino acids. Comparison of the human 
and chick sequences within the large collagenous domain consisting 
of 242 amino acids demonstrated 77.4% identity at the amino-acid 
level [14] . Alignment of the human sequences encoded by the entire 
1.0-kb BP180 cDNA with corresponding sequences in the chicken 
cDNA indicated 64.8% identity at the amino-acid level, suggesting 
that these two proteins may represent the same gene product in 
different species [14 J. 
To gain further insight into the conservation of BPAG2 se-
quences, we have screened a mouse keratinocyte (PAM cell) AZAPII 
cDNA library, which has allowed isolation of -1.8-kb mouse 
BPAG2 cDNA sequences. Comparison of the mouse sequences 
With published human and chicken BPAG2 sequences indicates that 
the 180-kDa BP antigen is a highly conserved collagenous protein 
of the stratified squamous epithelium. 
MATERIALS AND METHODS 
Isolation and Characterization of Mouse BPAG2 eDNA A 
rnouse keratinocyte (PAM cell) AZAPII cDNA library [17J (devel-
oped by Dr. Masayuki Amagai and kindly provided by Dr. Takashi 
Hashimoto and Dr. Takeji Nishikawa, Department of Dermatol-
ogy, Keio University School of Medicine, Tokyo, Japan) was 
screened with a human1.0-kb BPAG2 cDNA (BPI80-cDNA) [13J. 
Two positive clones were isolated and subjected to plaque purifica-
tiOn. In vivo excision and re-circularization resulted in the rescue of 
the cloned inserts in pBluescript SK, and the isolated recombinants 
Were digested with EcoRI endonuclease (Boehringer-Mannheim). 
The sizes of the inserts were estimated by electrophoresis on 1 % 
igarose gels in comparison with standard DNA markers (!'l'ew ~ng­
and BIOLabs). The ll1serts were also subjected to digestion with a 
vanety of restriction endonucleases, which .allowed precise align-
rnel1t of the overlapping cDNA. 
~ucleotide sequencing was performed by the dideoxynucleotide 
cham termination method, using the universal 17-mer primers 
(U .S. Biochemical) or with specific oligonucleotide primers synthe-
Sized on the basis of available nucleotide sequences. The amino-acid 
sequences were deduced from the cloned cDNA sequences, and the 
cornparison and alignment of the mouse sequences with previously 
published human BPAG2 and chicken "cornea-specific collagen" 
~quences was performed with the pc/GENE (IntelliGenetics, 
h OUntainview, CAl and FASTA [18J programs. The amino-acid 
Ol11ologies were corrected for the possibility that two or more 
al11mo-acid substitutions occurred in the same position. 
Northern Analysis For isolation of total RNA from epidermis of 
a newborn mouse, skin specimens were digested with dispase (2 U / 
1111) Overnight at 4 °C. The epidermis was peeled off, and RNA was 
~olated using the guanidinium isothiocyanate-cesium chloride 
enslty gradient centrifugation method [19J. The recovery of RNA 
~as calculated from the optical densities at 260 and 280 nm. Total 
t NA, 30 ,ug/lane, was fractionated on 1 % agarose gels using 2.2 M 
orrnaldehyde [20J. The mRNA transcripts were transferred to ni-
~rocellulose filters by vacuum transfer (VacuGene, LKB, Bromma, 
fi,eden) and immobilized by heating at 80 °C for 90 min. The 
b ters Were hybridized with the isolated cDNA labeled radioactive 
Ydnlck translation with a(32PJdCTP [21 J. The pre-hybridization 
an hybridization conditions were as described elsewhere [22J. The 
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Figure 1. Cloning and sequencing strategy of mouse 180-kDa bullous 
pemphigoid antigen cDNA (A), and schematic representation of the poly-
peptide structure deduced from cloned cDNA (B). A) A human 1.0-kb 
BPAG2 cDNA (BP180 cDNA) was used to screen a mouse keratinocyte 
cDNA library. Two overlapping cDNA (mpcBP2-A and B, the A and B 
clones) were isolated and sequenced by the strategy illustrated by arrows. 
Arrows with a box (0--+), sequences primed with univers~l and reverse 
primers; plaill arrows (--+), reactions primed with oligomers synthesized on 
the basis of available nucleotide sequences. A partial restriction enzyme map 
of the composite cDNA is indicated; the restriction enzymes used were P, 
PstI; A, Apa!; S, Sma!; B, BamHI. B) Amino acid sequences deduced from 
cloned cDNA identified three collagenous domains (~ containing imper-
fections (I) and separated by non-collagenous peptide segments (0). Also, the 
5' nucleotide sequences code for a non-collagenous domain (0). Computer 
analysis of the deduced amino-acid sequences identified the presence of a 
putative transmembrane domain (_), the presence of a potentially antigenic 
peptide segment C"), and an RGD peptide sequence (e). 
mRNA transcripts were visualized by autoradiography on X-ray 
films (X-Omat, Eastman-Kodak). 
RESULTS 
Isolation and Characterization of Mouse BPAG2 eDNA To 
isolate mouse BPAG2 cDNA, a keratinocyte (PAM cell) AZAPII 
cDNA library was screened with a human 1.0-kb BP180 cDNA. 
Initial screening yielded two positive clones (mpcBP2-A and B), 
which were characterized in detail (Fig 1). Initial size estimates of 
the inserts indicated that the A and B clones were approximately 1.0 
and 1.8 kb in size, respectively . Northern hybridizations of the B 
clone with total RNA isolated from mouse epidermis revealed the 
presence of a single mRNA transcript of -6 kb (Fig 2). This size is 
similar to the BPAG2 mRNA detected in human cells [l1J. Initial 
restriction enzyme digestions also suggested that the smaller clone 
was contained entirely within the larger one (Fig 1). Both clones 
were subsequently sequenced by dideoxynucleotide chain-termina-
tion method using the strategy shown in Fig 1. The composite 
nucleotide sequence demonstrated that the B clone consisted of 
1794 nucleotides (Fig 3). The A clone consisted of 1185 bp of 
nucleotide sequences, which were contained within the B clone and 
were identical with the corresponding sequences in the B clone. 
The composite nucleotide sequence revealed an open reading frame 
that was translated into a peptide sequence (Fig 3). 
Examination of the deduced amino-acid sequences revealed that 
the B clone encoded a polypeptide of 598 amino acids (Fig 3). The 
5' segment of the cDNA corresponded to a 227 -amino acid non-
collagenous segment (Fig IB). Within this region, there was a gly-
cine-rich sequence (amino acids 85 - 115) consisting of ten Gly-X-
Y repeats. In seven of them, Gly also occupied either the X or the Y 
position or both, whereas in three Gly-X-Y triplets the X and Y 
positions were occupied by amino acids other than Gly (Fig 3). 
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Figure 2. Northern hybridization of mouse epidermal RNA with the 
mouse BPAG2 eDNA, Total RNA, 30 fJ.g per lane, was electrophoresed as 
indicated in the text, and the N orthern filter was hybridized with the 
mpcBP2-B clone (see Fig 1), labeled radioactive with a[32P]dCTP. Autoradi-
ography revealed an mRNA transcript of the approximate size of 6 kb, 
estimated from its mobility in relation to ribosomal 28S RNA. 
However, the presence of Gly in the X and Y position and the 
absence of Pro suggest that this portion of the polypeptide may not 
be able to fold into a stable collagenous triple-helix. Towards the 3' 
end of the eDNA, the deduced amino acid sequences revealed the 
presence of three collagenous domains characterized by Gly-X-Y 
repeats (Fig 1B). The larger one (amino acids 228 -469) consisted of 
242 amino acids with ,a single imperfection in the Gly-X-Y repeat, 
i.e., a Gly-Ser-Gly sequence in the amino acid position 300-302 
(Fig 3). This large collagenous domain was separated from another 
42 amino-acid collagenous domain by a 12 - amino-acid non-collag-
enous segment. Further towards the 3' end of the eDNA, another 
non-collagenous segment of 20 amino acids, followed by a 40-
amino-acid collagenous domain, was detected (Fig 1B). Within the 
latter collagenous domain, the Gly-X-Y repeat was interrupted 
twice, once by a Gly-X-Y-X-Y-Gly sequence at position 556-561 
and once by a Gly-Glu-Gly sequence at position 570-572. Finally, 
the most 3' end of the clone revealed two Gly-Pro-Pro triplets, 
suggesting the presence of another collagenous domain down-
stream of the B clone (Fig 3). Taken together, these features suggest 
that the mouse BPAG2 is a collagenous protein consisting of several 
collagenous domains separated by non-collagenous segments. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Elucidation of Putative Protein Segments The cloning of 
mouse BPAG2 eDNA allowed us to evaluate the putative protem 
segments as deduced from the nucleotide sequences. Examination of 
these sequences revealed the presence of several interesting features. 
First, to examine the possibility that BPAG2 may contain a mem-
brane-associated segment, several computer programs were used to 
analyze the primary sequences. The method ofRao and Argos [23] 
predicted the presence of two transmembrane helices spanning 
from amino-acid position 93 to 122 and from 127 to 152 (Fig 3). 
The corresponding regions (amino acids 95 -115 and 131-151) 
were also identified as membrane-associated helices by the method 
of Eisenberg et al [24] . However, the method of Klein et al [25] 
identified only one of the regions (outer boundaries, amino aCids 
128-156) as a membrane-spanning segment, and classified t~e 
mouse BPAG2 as an integral membrane protein. Thus, BPAG2 IS 
predicted to contain definitely one and possibly two transmembrane 
segments. . 
Secondly, because the 180-kDa BP antigen serves as an autoantl-
gen in BP and HG, and the initial isolation of human BPAG2 
eDNA was accomplished by immunoscreening of a Agt11 expres-
sion library with a BP patient'S autoantibodies, a computer search 
for antigenic segments within the mouse BPAG2 primary se-
quences deduced from the eDNA was performed by the method of 
Hopp and Woods [26] . This search identified a 7 -amino-acid seg-
ment (amino acids 178-184) as a potential antigenic site for devel-
opment of autoantibodies (Fig 3). 
Finally, because the 180-kDa BP antigen is a component of 
hemidesmosomes, attachment complexes at the epidermal-ba~e­
ment membrane interface, a search for RGD,sequences (putative 
peptide segments in integrin-mediated cell attachment [27]) was 
performed. The presence of a single RGD sequence within the 
larger collagenous domain was detected in the position 349 - 351 
(Fig 3). 
Overall, these data suggest that BPAG2 may be a membran~-as­
socia ted protein participating in the attachment of basal keratlno-
cytes to the underlying basement membrane. 
Comparison of Mouse BPAG2 Sequences with Previ~usl~ 
Published Human and Chicken Sequences As indICate 
above, a 1.0-kb human 180-kDa BPAG2 eDNA has been 
previously published [13]. Comparison of these human sequences 
with the corresponding segment in a deduced polypeptide, sug-
gested to be chicken "cornea-specific collagen" [16J, indicated a 
high degree of homology [14]. In this study, we compared mouse 
sequences deduced from the cloned cDNA with published human 
[13] and chicken [16] amino acid sequences corresponding to ~ 
284-amino-acid segment (Fig 4). The alignment of human an 
mouse sequences indicated 87% identity at the amino acid lev~l. 
Strikingly, the imperfection in the Gly-X-Y repeat, Gly-Ser-G ~ 
within the large collagenous domain, was precisely conserve 
(amino acid position 73 - 75 in Fig 4). As in the case of the human 
sequence, the optimal alignment of the mouse sequence with the 
published chicken sequence required an introduction ~f a 
3-amino-acid gap in position 88-89 (Fig 4) . After such adJust-
ment, the overall identity between mouse and chicken sequences 
was 76%. Thus, BPAG2 sequences between these three species dem-
onstrates a relatively high degree of conservation within this seg-
ment. 
DISCUSSION 
In this study, we have isolated two cDNAciones, which bycompari-
son to h\lman sequences are clearly shown to represent mou~ 
BPAG2 sequences. The larger one of the mouse eDNA (th~ 
clone) consisted of three collagenous domains that contained Im-
perfections in the Gly-X-Y repeat sequences, and that we~e se~t: 
rated by non-collagenous segments. The largest of the putatiVe c 'cy 
lagenous domains, a 242 - amino-acid segment, had an 87% Ident! 
with the corresponding segment in human BPAG2. Strikingly, t le 
single imperfection in the Gly-X-Y sequence, Gly-Ser-Gly, ;~; 
precisely conserved between the human and mouse sequences. 
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ATT GTG GAG AAA GAG AAG AGA GGA GGT AAG AAA GAG ATG GAA GTG 
lIe Leu e lu Lys Asp Asn Thr Pro Ala Lys Lys Glu Met Glu Leu 
46 TTG ATG ATG AGG AAG GAG AGT GGG AAG GTG TTG AGG GGG TGG GGT 
16 Leu lIe Met Thr Lys Asp Ser Gly Ly s Val Phe Thr Al a Ser Pro 
91 GGG AG G ATG TGT TGA AGT TGG TTT TGA GAA GAG AGG GTG AAA AAG 
31 Ala Thr l I e Ser Ser Thr Ser Phe Ser GIll Asp Thr Leu Lys Lys 
136 GAG AAG GAG GGT GGA TAT GGG GGT GAG AGG TGG GTG AAG GGA GAT 
46 Glu Ly s Gln Ala Al a Tyr Ala Ala Asp Thr Gys Le u Lys Al a Asp 
181 GTG AAT GGA GAG GTA AAT AGG GTG TGG AGA AAG AGG AAG ATG AGG 
61 Va l Asn Gly Asp Leu Asn Thr Val Ser Thr Lys Ser Lys Met Thr 
226 TGG GGA GAA AAG GAT GGG TAG GAG GGA GGT GGG GGT GGT GGG AGA 
76 Ser Ala Glu Asn His Gly Tyr Asp Arg Gly Gly Gly Gly Gly Arg 
271 GGG AAA GGG GGA GGT GGT GGT GGT GGG GGT GGT GGG GGT GGG GGG 
91 e ly Lys ely Gly Gly Ala Gly Gly Gly Gly Gly Gly e l y Gly Ala 
316 AGT GGG GGT GGA GGA GGA TGG GGG GGT GGA GGA GGG TGG TGG GGG 
106 Ser Gl y Gly Gly Gly Al a Trp Gly Ala Ala Pro Ala Trp Gys Pro 
361 TGG GGG TGG TGG TGG AGG TGG TGG AAG TGG eTG GTG GGe eTG eTG 
12 1 Gys Gly Ser Gys Gys Ser Trp Trp Lys Trp Le u Le u Gly Leu Leu 
406 GTG AGe TGG GTG eTG eTG eTG GGT eTG eTe TTG GGe eTG ATT GGT 
136 Le u Thr Tro Leu Leu Le u Leu Gly Leu Leu Phe ely Leu lIe Ala 
451 GTG GGG GAG GAG GTA AGA AAG CTG AAG GCC CGC GTG GAG GAG CTG 
151 Leu Ala Glu Glu Val Arg Lys Le u Lys Ala Arg Val Glu Glu Leu 
496 GAA AAG ACC AAG GTG GTA TAT CAT GAC GTC CAG ATe; ,;AC AAA AGC 
166 Glu Lys Thr Lys Val Leu Tyr Hi s As p Val Gl n Met As p Lys Ser 
54 1 AAC AGG GAC GGG CTG GAG GGC GAG GGA CCC AGG GTG GGA GGT GGA 
181 Asn ArB Asp Arg Leu Gln Ala e lu Ala Pro Ser Leu Gly Pro Gl y 
586 TTA GGC AAG GGT GAG GTG GAG GGG TAG AGC GAG GAG GGG ATG TGG 
196 Leu Gly Lys Ala Glu Leu Asp Gly Tyr Ser Gln Glu Ala He Trp 
631 CTG TTT GTA AGG AAG AAG GTG ATG AGG GAG GAG GAG AAG GGG AAT 
211 Le u Phe Va l Arg As n Lys Leu Met Thr Gl u Gin Glu As n Gl y Asn 
676 GTG AGA GGA AGT GGT GGT GGA AAA GGT GAG ATG GGG AGT GAA GGA 
226 Le u Arg Gly Ser Pro Gly Pro Lys Gly Asp Met Gl y Ser Gln Gly 
721 GGT AAA GGA GAG GGA GGG GTT GGT GGG AGG GGA GGT ATG GGT GGG 
241 Pro Lys Gly Asp Arg Gly Leu Pro Gly Thr Pro Gly He Pro Gl y 
766 CGG GTG GGG GAG GGT GGG GGG GAA GGA GGA AAG GGA GAA AAA GGG 
256 Pro Le u Gly His Pro Gly Pro Glu Gly Pro Lys Gl y Gln Lys Gl y 
811 AGG ATT GGA GAT GGT GGG ATG GAA GGA GGG ATA GGG CAG AGA GGA 
271 Ser H e Gl y Asp Pro Gl y Met Glu Gl y Pro H e Gly Gin Arg Gly 
856 GTA GGA GGG GGG ATG GGA GCT GGT GGT GAA GGG GGG GGT GGT GGG 
286 Leu Al a Gly Pro Met Gly Pro Arg Gly Glu Pro Gly Pro Pro Gl y 
901 
301 
946 
31 6 
991 
331 
1036 
346 
1081 
36 1 
1126 
376 
1171 
391 
1216 
406 
126 1 
42l 
1306 
436 
135 1 
45 1 
1396 
466 
1441 
481 
1486 
496 
1531 
511 
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TGT GGA GAG AAA GGA GAG AGA GGG ATT GGT GGT GAA GAA GGT GGT 
Ser Gl y Glu Lys Gl y Asp Arg Gly H e Ala Gl y Glu Gln Gly Pro 
GAG GGG GTT GGT GGT GTG GGA GGT GGT GGG GGT GTG AGA GGT GAG 
Gin Gly Leu Pro Gly Va l Pro Gl y Pro Pro Gl y Le u Arg Gly Hi s 
AGG GGG TGT GGT GGT GGG GAA GGG GGG GGA GGT GGT GTG GGT GGG 
Ser Gly Se, Pro Gly Pro Gln Gly Pro Pro Gly Ala Val Gly Pro 
GAA GGG GTG CGA GCT GAC GTG GGA CTT GGT GGT GTG AAA GGT GAC 
Gi n Gly Leu Arg Gly. ASQ Val Gly Leu Pro Gly Va l Lys Gly Asp 
AAA GGA GTC ATG GGA CGA GGA GGA CCG AAA GGT GAG CAG GGT GAG 
Lys Gly Leu Met Gl y Pro Pro Gly Pro Lys Gly Asp Gin Gly Glu 
AAG GGA GGG AGA GGG GTC AGA GGG GAG GCT GGG ATT GGA GGT TTG 
Lys Gly Pro Arg Gl y Leu Thr Gly Glu Pro Gly He Arg Gly Leu 
GGT GGA GGT GTG GGT GAA GGG GGA GGG AAA GGG GGA ATG GGT GGG 
Pro Gly Ala Val Gl y Glu Pro Gly Ala Lys Gly Al a Met Gly Pro 
GGT GGG GGT GAT GGA GAG GAA GGT TGG AGA GGT GAA GAA GGG TTG 
Al a Gly Ala Asp Gl y Gl n Gi n Gl y Se r Arg Gl y Glu Gln Gly Leu 
AGA GGG ATG GGT GGA AGG GGG GGG GGG GGA GGA GGG GGT GGA GAG 
Thr Gly Met Pro Gly Thr Arg Gly Pro Pro Gly Pro Ala Gly Asp 
GGA GGA AAG GGA GGT GTG AGA GGA GGG GAG GGA GGT GAG GGA Grr 
Pro Gl y Lys Pro Gly Leu Th r Gl y Pro Gln Gly Pro Gin Gl y Leu 
GGT GGT AGG GGT GGG GGA GGA GGG AGT AAA GGC GAA GCC GGC GCT 
Pro Gly Se, Pro Gly Arg Pro Gly Thr Lys Gly Glu Pro Gly Ala 
GCC GGG AGA GT~ I ATG AGT TGA GAG GGA TGA TGA ACA ATC AGT GTG 
Pro Gl y Arg Val Met Thr Ser Glu Gly Ser Ser Thr I I e JThr Val 
CCG GGA GCT CCC GGA GCT GGT GGT GGG ATG GG T CGG GGA GGA CCT 
Pro Gly Pro Pro G1y Pro Pro Gly Al a Met Gly Pro Pro Gl y Pro 
GGA GGG ACG GGA GGT CCA GGT GGC CCT GCT GGT CTG CCA GGA GAA 
Pro Gly Thr Pro Gly Pro Ala Gl y Pro Ala Gly Leu Pro Gl y Gln 
CAA GGG CCA CGA GGG GAG GGA GGA GTG GCT GGT GAG TGA iTTC CTA 
Gin Gl y Pro Arg Gl y Glu Pro Gl y Le u Al a Gl y Asp Ser Phe Leu 
1576 AGG AGT GGC AGC TGG ATG TGT GAG GTG GTG TGT GGG GAA GGT GTT 
526 Ser Se r Gly Ser Ser He Ser Glu Va l Le u Ser Ala G1n Gly Val 
l62l 
541 
1666 
556 
1711 
571 
1 756 
586 
GAG 
Asp 
GGG 
Gly 
GAA 
Glu 
GAC 
Asp 
TTA GG~ I ~GT 
Leu Arg Gl y 
GG T TGG ATG 
Pro Ser Ile 
GGC GTA GGA 
Gly Va l Pr o 
TGA GAA ACC 
Ser Glu Thr 
GCC GGT GGC GGA 
Pro Pro Gly Pro 
GGA GGG GGG CCA 
Pro Gly Pro Pro 
GGC GGA CCG GGG 
Gl y Pro Pro Gl y 
TTC TTC ACT ~GGG 
Phe Phe Thr Gly 
GGT GGG GGA GGA GGG GGA GGA 
Pro Gl y Pro Arg Gl y Pro Pro 
GGA GGC AGA GGG CGA GGA GGG 
Gly Pro Arg Gly Pro Pr o Gly 
GCA CGA GGA TCC TT~IGTG ACT 
Pro Pro Gly Ser Phe Leu Thr 
CCT CGA GGT CCA CG~ j1 794 
Pro Pro Gly Pro Pro 598 
Figure 3. Nuclcotidc and deduced a mino-acid sequences of the mouse 180-kDa bullous pemphigoid antigen GDNA, mpGBP2-B. Three collagenous dom a ins 
charactcrized by repeating Gly-X-Y sequcnGe, and a carboxy-terminal segment consisting of two Gly-X-Y triplcts are boxed by all ollt/ille. In addition, the 
sequcncc analyses revealed the presence of a Gly-rich sequence at the amino-acid position 85 -115 (l/lJderli/led) . Computer analysis of the deduced peptide 
~equcnces identified a putative transmembrane domain a t the position 131-151 (bold, ullderli/Jed), and a potentially antigeniG peptide segment a t the position 
78-184 (dol/ble JlIJder/i/led). An Arg-Gly-Asp (RGD) sequence was identified at the position 349-352 (italics, u/Jder/i/Jed) . 
overall homology between the published 1.0-kb human BPAGZ 
al11tno-acid sequence and the corresponding segment in the mouse 
eDNA was 86%. Furthermore, Northern hybridizations with the 
l110use eDNA identified a single mRNA of - 6 kb, the size 
~eviously shown to correspond to human BPAGZ mRNA [11]. 
lhus, these features unequivocally identify the mouse cDNA 
e Ones to correspond to the 180-kDa BP antigen sequences. 
d Detailed examination of the primary amino-acid sequences de-
uced from the cloned eDNA revealed the presence of several inter-
esti.ng features. Specifically, computer analysis of the putative 
:.~Ino-acid sequences, utilizing three independent programs, iden-
Bpcd a transmembrane domain. The same region in the human 
AGZ has also been identified as a putative transmembrane do-
111' [ th atn Z8] . Furthermore, two of three computer programs predicted 
B; presence of a second membrane-associated segment in mouse 
AGZ. These observations suggest that BPAGZ may be a trans-
l11el11brane protein spanning from the cytoplasm of basal keratino-
~Y~s to the extracellular milieu on the surface of cells apposed to the 
t n crlYl11g cutaneous basement membrane. Previous immunoelec-
ron microscopic studies have demonstrated co-localization of 
BPAGI and BPAGZ in hemidesmosomes, attachment structures at 
the interface between the basal keratinocytes and the lamina lucida 
at the epidermal-dermal junction [4-6,11]. It is conceivable, there-
fore, that these two BP antigens may participate in a trans-mem-
brane interaction, together with other hemidesmosomal proteins, 
including the 0l6{J4 integrins, in securing the attachment of basal 
keratinocytes to the basement membrane. 
Elucidation of the primary amino acid sequences deduced from 
the cloned mouse BPAGZ cDNA identified within the non-collage-
nous domain a 7 -amino-acid segment that was predicted to be 
antigenic by computer analyses (Fig 3) [Z6]. A BP autoantibody-
reactive site on human BPAGZ was initially mapped to a 
95 -amino-acid segment that encompassed the N-teIminal portion 
of the major collagenous domain and a short stretch of the adjacent 
non-collagenous region [13]. More recently, this antigenic domain 
within human BPAGZ has been shown to be restricted to a 14 -
amino-acid segment of the non-collagenous region that is recog-
nized by both BP and HG autoantibodies [Z8 ,Z9] . The predicted 
antigenic epitope region consisting of 7 amino acids in the mouse 
BPAGZ corresponds to the 14-amino-acid segment in the human 
262 LI ET AL 
HUMAN GSPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQKGSVGDPGM - 5 0 
.. ::::::::::::: 
MOUSE GSPGPKGDMGSQGPKGDRGLPGTPGIPGPLGHPGPEGPKGQKGSIGDPGM - 50 
CHICKEN GEPGMKGDMGLQGPKGDRGLPGXPGIPGPVGHQGPEGPKGQKGSMGDPGM - 5 0 
HUMAN m:m:::::::m:::~~:::p::::::::::r:::::: : ::: 
EGPMGQRGREGLPGPRGEPGPYKGDRGXAGPPGP- - - PGPPGSAGL - 97 
MOUSE 
CHICKEN 
HUMAN KGSSGSPGPQGPPG PVGLQGLRGEVGLPGVKGDKGPMGP PGI KGDQGEKG - 150 
:: :::.::::: ..... . 
MOUSE RGHSGSPGPQGPPGAVGPQGLRGDVGLPGVKGDKGLMGPPGPKGDQGEKG -150 
CHICKEN KGPMGSPG PQGPPGPPGLQGFRGEAGLPGAKGEKGATG P PGPKGDQGEKG - 147 
HUMAN PRGLTGEPGMRGLPGAVGEPGAKGAMGPAGPDGHQGPRGEQGLTGMPGIR - 200 
.. .. ..... , .. :::::::::: ::. 
MOUSE PRGLTGEPGIRGLPGAVGEPGAKGAMGPAGADGQQGSRG EQGLTGMPGTR - 200 
CHICKEN AHGMTGEQGSRGIPGPPGEPGAKGPAGQAGRDGQPGERGEPGLMGXPGAR - 197 
HUMAN GPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGK TSEGSSlI -250 
::: ... :::::: 
MOUSE GPPGPAGDPGKPGLTGPQGPQGLPGSPGRPGTKGEPGAPGR TSEGSST -250 
CHICKEN GPPGPSGDTGEPGLTGPQGPPGLPGNPGRPGAKGEPGAPGK SAEGSST - 24 7 
HUMAN PPGPPGAMGPPGPPGAPGPAGPAGLPGHQ -28 4 
MOUSE PPGPPGAMGPPGPPGTPGPAGPAGLPGQQ -2 84 
CHICKEN PPGPXGPIGPTGPPGVPGPVGPAGLPGQQ - 281 
Figure 4. Comparison of amino-acid sequences corresponding to two col-
lagenous domains separated by a non-collagenous peptide segment (shaded 
box), as deduced from mouse cDNA and from published human [13] and 
chicken [16] cDNA. Double dots, identical amino acids; single dots, conserved 
amino acids. Note the presence of a Gly-X-Gly imperfection within the 
large collagenous domain in a conserved position 73 - 75 (box). 
sequence. Thus, this segment of the protein is likely to be a major 
antigenic site giving rise to autoantibodies in BP and HG. In this 
context, it should be noted that there is apparent immunologic 
heterogeneity of antigen recognition among the sera from different 
patients with herpes gestationis. For example, a recent immunofluo-
rescence study, which examined trypsinized basal keratinocytes by 
indirect immunofluorescence with sera from patients with herpes 
gestationis, demonstrates two distinct patterns [30]. One of them 
was polar in a pattern similar to that observed with bullous pemphi-
goid serum, whereas the other showed uniform staining around the 
cell periphery. Thus, the 180-kD bullous pemphigoid antigen is 
only one of possibly several proteins serving as autoantigens in 
herpes gestationis. 
The hypothesis that the 180-kDa BPAG may serve a function in 
cell attachment was strengthened by detection of an Arg-Gly-Asp 
(RGD) tri-peptide sequence, which has been suggested to playa role 
in integrin-mediate~ attachment of cells to the extracellular matrix 
of connective tissue [27] . However, it is unclear whether this RGD 
sequence is functional, because this sequence is not conserved. Spe-
cifically, the RGD sequence is replaced both in human and chicken 
BPAG2 by RGE sequence [13,16]. Thus, the functionality of the 
RGD sequence identified within the large collagenous domain 
of the mouse BPAG2 remains to be demonstrated by functional 
analysis. 
The collagens comprise a family of closely related, yet genetically 
distinct, proteins and there are as many as 30 distinct genes within 
the human genome encoding these different polypeptides [31] . Re-
cently, several novel collagenous proteins have been predicted from 
cloned eDNA. For example, a chicken eDNA was recently isolated, 
and the corresponding protein was predicted to be a collagen con-
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sisting of several collagenous domains separated by non-collagenouS 
regions [16]. The authors suggested that the isolated chicken eDNA 
encoded a "cornea-specific collagen" [16]. As indicated previously, 
this "cornea-specific collagen" has striking similarity to human 
BPAG2 sequences [14]. Further comparison of the mouse eDNA 
cloned in this study demonstrated a remarkable conservation of 
sequences. The homology at the amino-acid level within the large 
collagenous domain was 76%, and the overall homology between 
the 1.8-kb mouse eDNA (the B clone) and the corresponding seg-
ment in the "cornea-specific collagen" was 73%. These observa-
tions clearly suggest that the "cornea-specific collagen" is the 
chicken homologue of BPAG2, and its expression may not be re-
stricted to the cornea. 
In conclusion, we have isolated and characterized eDNA corre-
sponding to mouse 180-kDa BP antigen sequences. These data, id 
comparison to previously elucidated sequences in human an 
chicken proteins, predict that the 180-kDa BP antigen is weJl con-
served, and it presumably plays a significant role in the attachment 
of basal keratinocytes to the underlying basement membrane by 
hemidesmosomes. Finally, it is conceivable that mutations in the 
BPAG2 gene, by analogy to other cutaneous basement membrane-
zone components, such as type VII collagen [32-34], can lead to 
fragility of the tissue at the dermal-epidermal junction, and could 
manifest clinically as a form of epidermolysis bullosa. 
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